Cargando…
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19
Autores principales: | Salton, Francesco, Confalonieri, Paola, Torregiani, Chiara, Ruaro, Barbara, Confalonieri, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502891/ https://www.ncbi.nlm.nih.gov/pubmed/37343288 http://dx.doi.org/10.1513/AnnalsATS.202304-329LE |
Ejemplares similares
-
Reply: Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19
por: Pitre, Tyler, et al.
Publicado: (2023) -
Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
por: Salton, Francesco, et al.
Publicado: (2020) -
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
por: Pelosi, Paolo, et al.
Publicado: (2022) -
Chronic Obstructive Pulmonary Disease Definition: Is It Time to Incorporate the Concept of Failure of Lung Regeneration?
por: Confalonieri, Marco, et al.
Publicado: (2022) -
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2022)